MetaCap

Cartesian Therapeutics (RNAC) News

NASDAQ: RNACHealth CareBiotechnology: Pharmaceutical PreparationsUSD

6.14+0.25 (+4.24%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RNAC news summary

We found 1 recent headline mentioning Cartesian Therapeutics (RNAC): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, RNAC is up 4.24% at $6.14. The most recent story, "Amgen (AMGN) Tops Q3 Earnings and Revenue Estimates", was published by Nasdaq on Nov 3, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cartesian Therapeutics headlines

Stocks mentioned alongside RNAC

Compare RNAC